ChromaVision Medical Systems President to Discuss Recent FDA Approval On RadioWallStreet Internet Broadcast.PHILADELPHIA--(BUSINESS WIRE)--July 29, 1999-- ChromaVision Medical Systems (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CVSN) President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Douglas S Douglas, city, Isle of Man Douglas, city (1991 pop. 19,950), capital of the Isle of Man, Great Britain. It is a popular resort, connected by rail to Ramsey and Port Erin, on the Irish Sea. Tourism is the chief industry. . Harrington MD will interview on RadioWallStreet today, Thursday, July 29, 1999 at 4:30 PM EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT , Investor Broadcast Network f/k/a Vcall Corporation announced. The interview will be conducted by Joseph Garner of Emerald Research and will address the recent FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval and future growth prospects for ChromaVision. To listen to the interview, investors should go to the RadioWallStreet website located at http://www.vcall.com and click on the RadioWallStreet event. RadioWallStreet is an Investor Broadcast Network service that broadcasts senior executive interviews, analyst roundtable discussions, seminars and other events of interest to the investment community. RadioWallStreet events are open to the investing public and may be heard over the Internet. Questions for this RadioWallStreet event may be submitted in advance by e-mailing greg@vcall.com. Please reference date and time in the Subject of the e-mail. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion